SCHEMBL979078

SCHEMBL979078

CCCC(CC)CCCO

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
CA2 P00918 2/20 0.43
LMNA P02545 4/20 0.42
TDP1 Q9NUW8 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
TSHR P16473 5/20 0.41
CYP3A4 P08684 3/20 0.41
HSD17B10 Q99714 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.35
CHRM1 P11229 1/20 0.35
AKR1A1 P14550 1/20 0.35
CHRM3 P20309 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
ADRA1A P35348 1/20 0.35
HRH1 P35367 1/20 0.35
DRD3 P35462 1/20 0.35
SLC6A3 Q01959 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16897049 1.00 ALDH1A1 (0.54) ALDH1A1CA2LMNATDP1SMN1; SMN2
SCHEMBL16896971 1.00 ALDH1A1 (0.54) ALDH1A1CA2LMNATDP1SMN1; SMN2
SCHEMBL16897039 0.92 ALDH1A1 (0.52) ALDH1A1CA2LMNATDP1SMN1; SMN2
SCHEMBL3090935 0.92 ALDH1A1 (0.52) ALDH1A1CA2LMNATDP1SMN1; SMN2
SCHEMBL9173076 0.92 ALDH1A1 (0.55) ALDH1A1CA2LMNATDP1SMN1; SMN2
SCHEMBL3100777 0.90 ALDH1A1 (0.50) ALDH1A1CA2LMNATDP1SMN1; SMN2
SCHEMBL6446922 0.90 ALDH1A1 (0.50) ALDH1A1CA2LMNATDP1SMN1; SMN2
SCHEMBL12559649 0.90 ALDH1A1 (0.50) ALDH1A1CA2LMNATDP1SMN1; SMN2
SCHEMBL368279 0.90 ALDH1A1 (0.50) ALDH1A1CA2LMNATDP1SMN1; SMN2
SCHEMBL6440117 0.90 ALDH1A1 (0.50) ALDH1A1CA2LMNATDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9688838-B1 Diisononyl terephthalate plasticizer and its use as well as process for producing the same NAN YA PLASTICS CORPORATION (TW) 2017-06-27 US claimed
EP-3094613-A1 PROCESSES FOR THE SYNTHESIS OF CHIRAL 1-ALKANOLS Purdue Research Foundation, Inc. (US) 2016-11-23 EP claimed
WO-2015106045-A1 PROCESSES FOR THE SYNTHESIS OF CHIRAL 1-ALKANOLS PURDUE RESEARCH FOUNDATION (US) 2015-07-16 WO claimed
US-12069936-B2 Electronic device and method for slot-die depositing layers of the same EMPA Eidgenössische Materialprüfungs-und Forschungsanstalt (CH) 2024-08-20 US disclosed
US-12063847-B2 Method for forming an organic element of an electronic device MERCK PATENT GMBH (DE) 2024-08-13 US disclosed
EP-3558903-B1 PROCESS FOR PHOSPHORYLATING A COMPLEX ALCOHOL AVECHO BIOTECHNOLOGY LTD (AU) 2024-07-03 EP disclosed
US-11882762-B2 Formulation and method for preparation of organic electronic devices FLEXENABLE TECHNOLOGY LIMITED (GB) 2024-01-23 US disclosed
WO-2023223888-A1 METHOD FOR PRODUCING POLYCARBONATE RESIN, AND ALICYCLIC POLYCARBONATE RESIN 旭化成株式会社 2023-11-23 WO disclosed
EP-3387077-B1 FORMULATIONS CONTAINING KETONES COMPRISING NON-AROMATIC CYCLES MERCK PATENT GMBH (DE) 2023-10-18 EP disclosed
US-11753435-B2 Process AVECHO BIOTECHNOLOGY LIMITED (AU) 2023-09-12 US disclosed
US-20230159727-A1 STERICALLY HINDERED AMINE STABILIZER MIXTURES BASF SE (DE) 2023-05-25 US disclosed
EP-0426198-B1 Ultraviolet photopolymerization of pressure sensitive adhesive formulations ADCO PRODUCTS INC (US) 1994-04-27 EP disclosed
US-5192766-A Platelet activating factor antagonist SANKYO COMPANY, LIMITED (JP) 1993-03-09 US disclosed
US-5183833-A Using a wavelength band of about 280 to 350 nm and a surface light intensity of 4.0 miliwatts/cm**2 on an acrylic ester/polar unsaturated compound solvent-free formulation ADCO PRODUCTS INC. (US) 1993-02-02 US disclosed
WO-1991018905-A1 RADICICOL DERIVATIVES, THEIR PREPARATION AND THEIR ANTI-TUMOR ACTIVITY SANKYO COMPANY LIMITED (JP) 1991-12-12 WO disclosed
EP-0460950-A1 Radicicol derivatives, their preparation and their anti-tumour activity Sankyo Company Limited (JP) 1991-12-11 EP disclosed
EP-0426198-A2 Ultraviolet photopolymerization of pressure sensitive adhesive formulations ADCO PRODUCTS, INC. (US) 1991-05-08 EP disclosed
US-4968558-A MULTILAYER NALCO CHEMICAL COMPANY (US) 1990-11-06 US disclosed
US-4931347-A Translucent pressure-sensitive adhesive systems NALCO CHEMICAL COMPANY (US) 1990-06-05 US disclosed
EP-0094456-B1 PREPARATION OF ALCOHOLS FROM OLEFINS HAVING FROM 3 TO 7 CARBON ATOMS MONSANTO COMPANY (US) 1986-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159727-A1 STERICALLY HINDERED AMINE STABILIZER MIXTURES PYM1, H1-4, C5 ALDH1A1 1799/4885CA2 2784/4885LMNA 2637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.